CLNN

Clene (CLNN)

About Clene (CLNN)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high

$4.25

Daily low

$4.10

Price at open

$4.16

52 Week High

$13.50

52 Week Low

$3.53

Market cap

53.5M

Dividend yield

Volume

58,955

Avg. volume

85,118

P/E ratio

-1.31

Clene News